https://www.selleckchem.com/products/sr59230a.html
The majority of trials examine drug reposition (repurposing), which seems to be a good and effective option. Many drugs have been repurposed in COVID-19 therapy including remdesivir, favipiravir, tocilizumab and baricitinib. The aim of this review is to highlight (based on existing and accessible clinical evidence on ongoing trials) the current and available promising drugs for COVID-19 and outline their characteristics.A better understanding of their interaction with cell-based tissue is a fundamental prerequisite towards the safe pro
Gefällt mir
Kommentar
Teilen
